![Heather Huet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heather Huet
Direttore Tecnico/Scientifico/R&S presso
DAY ONE BIOPHARMACEUTICALS, INC.
Profilo
Heather Adkins Huet is currently the Director at Gammadelta Therapeutics Ltd. and the Chief Scientific Officer at Day One Biopharmaceuticals, Inc. Dr. Huet holds a doctorate from Harvard University and completed undergraduate studies at The University of Texas at Austin.
Posizioni attive di Heather Huet
| Società | Posizione | Inizio |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Gammadelta Therapeutics Ltd.
 Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Direttore/Membro del Consiglio | - |
Formazione di Heather Huet
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
